Slowing lesion growth can delay the progression of GA
SYFOVRE was proven to slow the growth of GA lesions
SYFOVRE was studied in 2 clinical trials of over 1200 people with GA. In both trials, lesion growth slowed down for patients who received SYFOVRE versus those who did not.